Effects of treatment of myofascial trigger points on the pain of fibromyalgia

Current Pain and Headache Reports

Volumn 15, Issue 5, 2011, Pages 393-399

  Giamberardino, Maria Adele ^a   Affaitati, Giannapia ^a   Fabrizio, Alessandra ^a   Costantini, Raffaele ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Anesthetic; Antidepressants; Central sensitization; Comorbidity; Fibromyalgia; Fibromyalgia syndrome; Local injection; Local pain; Management; Musculoskeletal pain; Myofascial pain; Myofascial trigger points; Pain syndrome; Pathophysiology; Peripheral pain generators; Pressure pain threshold; Referred pain; Taut band; Tender point

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BUPIVACAINE; CORTICOSTEROID; DULOXETINE; FLUOXETINE; LIDOCAINE; MILNACIPRAN; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AEROBIC EXERCISE; ARTICLE; COGNITIVE THERAPY; FIBROMYALGIA; HUMAN; HYPERALGESIA; MECHANICAL STIMULATION; MULTIPLE CYCLE TREATMENT; MUSCULOSKELETAL PAIN; MYOFASCIAL PAIN; NOCICEPTION; PAIN THRESHOLD; PATHOPHYSIOLOGY; PHYSIOTHERAPY; QUALITY OF LIFE; REFERRED PAIN; RELAXATION TRAINING; RESISTANCE TRAINING; TRAPEZIUS MUSCLE; TRIGGER POINT;

ANIMALS; CLINICAL TRIALS AS TOPIC; FIBROMYALGIA; HUMANS; MYOFASCIAL PAIN SYNDROMES; PAIN MEASUREMENT; PAIN THRESHOLD; TREATMENT OUTCOME; TRIGGER POINTS;

EID: 80755132304     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-011-0205-3     Document Type: Article

References (37)

1. Mense S, Gerwin RD (Eds): Muscle Pain. Diagnosis and Treatment. Heidelberg, Dordrecht, London, New York: Springer; 2010: 365 pp. This book provides a comprehensive description of musculoskeletal pain conditions, particularly myofascial pain syndromes from trigger points and fibromyalgia, and critically discusses their overlap, interaction, and implications for therapy.
2. Cummings M. Regional myofascial pain: diagnosis and management. Best Pract Res Clin Rheumatol. 2007;21:367-87. (Pubitemid 46804372)
3. Borg-Stein J. Management of peripheral pain generators in fibromyalgia. Rheum Dis Clin North Am. 2002;28:305-17. (Pubitemid 34733185)
4. Gerwin RD. Classification, epidemiology, and natural history of myofascial pain syndrome. Curr Pain Headache Rep. 2001;5:412-20.
5. Podichetty VK, Mazanec DJ, Biscup RS. Chronic non-malignant musculoskeletal pain in older adults: clinical issues and opioid intervention. Postgrad Med J. 2003;79:627-33. (Pubitemid 38019212)
6. Mense S, Simons DG, Russell IJ, editors. Muscle pain. Understanding its nature, diagnosis, and treatment. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 385.
7. Giamberardino MA, Affaitati G, Fabrizio A, Costantini R: Myofascial pain syndromes and their evaluation. Int J Clin Pharmacol Ther 2011; in press.
8. Simons DG, Travell JG, Simons LS (Eds): Travell & Simons' Myofascial Pain and Dysfunction. The Trigger Point Manual, Vol 1. Upper Half of Body, 2nd edn. Baltimore: Williams & Wilkins; 1999 1038 pp
9. Alvarez DJ, Rockwell PG. Trigger Points: diagnosis and management. Am Fam Physician. 2002;65:653-60. (Pubitemid 34175039)
10. Majlesi J, Unalan H. Effect of treatment on trigger points. Curr Pain Headache Rep. 2010;14:353-60.
11. Graff-Radford SB. Myofascial pain: diagnosis and management. Curr Pain Headache Rep. 2004;8:463-7.
12. Vecchiet L, Giamberardino MA, Saggini R. Myofascial pain syndromes: clinical and pathophysiological aspects. Clin J Pain. 1991;7:16-22.
13. Affaitati G, Fabrizio A, Savini A, et al. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds. Clin Ther. 2009;31:705-20.
14. Vecchiet L, Giamberardino MA, de Bigontina P, Dragani L: Comparative sensory evaluation of parietal tissues in painful and nonpainful areas in fibromyalgia and myofascial pain syndrome. In Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Management. Edited by Gebhart GF, Hansmond DL, Jensen TS. Vol 2. Seattle: IASP Press; 1994: 177-185.
15. Shah JP, Phillips TM, Danoff JV, Gerber LH. A in vivo microanalytical technique formeasuring the local biochemicalmileu of human skeletal muscle. J Appl Physiol. 2005;99:1977-84. (Pubitemid 41547200)
16. Kuan TS. Current studies on myofascial pain syndrome. Curr Pain Headache Rep. 2009;13:365-9.
17. Srbely JZ. New trends in the treatment and management of myofascial pain syndrome. Curr Pain Headache Rep. 2010;14:346-52.
18. Scott NA, Guo B, Barton PM, Gerwin RD. Trigger point injections for chronic non-malignant musculoskeletal pain: a systematic review. Pain Med. 2009;10:54-69.
19. Ho KY, Tan KH. Botulinum toxin A for myofascial trigger point injection: a qualitative systematic reviews. Eur J Pain. 2007;11:519-27.
20. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160-72. (Pubitemid 20098653)
21. Wolfe F, Clauw DJ, Fitzcharles MA, et al.: Fibromyalgia Criteria and Severity Scales for Clinical and Epidemiological Studies: A Modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011 Feb 1. Epub ahead of print.
22. Abeles AM, Pillinger MH, Solitar BM, Abeles M. Narrative review: the pathophysiology of fibromyalgia. Ann Int Med. 2007;146:726-34. (Pubitemid 351640000)
23. Bennett RM. Clinical manifestations and diagnosis of fibromyalgia. Rheum Dis Clin North Am. 2009;35:215-32.
24. Robinson ME, Craggs JG, Price DD, et al.: Gray Matter Volumes of Pain-Related Brain Areas are Decreased in Fibromyalgia Syndrome. J Pain 2010 Dec 9. Epub ahead of print.
25. Giamberardino MA: Update on Fibromyalgia Syndrome. PCU 2008; XVI(4):1-6.
26. Carville SF, Arendt-Nielsen S, Bliddal H, et al. EULAR evidence based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008;67:536-41. (Pubitemid 351498437)
27. Sommer C: Fibromyalgia: a clinical update. PCU 2010; XVIII (4):1-4.
28. Xu YM, Ge HY, Arendt-Nielsen L: Sustained nociceptive mechanical stimulation of latent myofascial trigger points induces central sensitization in healthy subjects. J Pain doi10.1016/j. pain.2010.03.010.
29. Cakit BD, Taskin S, Nacir B, et al. Comorbidity of fibromyalgia and cervical myofascial pain. Clin Rheumatol. 2010;29:405-11.
30. Ge HY, Nie H, Madeleine P, et al. Contribution of the local and referred pain from active myofascial trigger points in fibromyalgia syndrome. Pain. 2009;147:233-40.
31. Alonso-Blanco C, Fernández-de-Las-Peñas C, Morales-Cabezas M, et al.: Multiple Active Myofascial Trigger Points Reproduce The Overall Spontaneous Pain Pattern inWomen With Fibromyalgia and are Related toWidespread Mechanical Hypersensitivity. Clin J Pain. 2011 Feb 28. Epub ahead of print. This article demonstrates the high prevalence of active TrPs in multiple muscles of FMS patients, as compared to control patients, and the correlation between TrP activity and FMS pain and hypersensitivity.
32. Ge HY. Prevalence of myofascial trigger points in fibromyalgia: the overlap of two common problems. Curr Pain Headache Rep. 2010;14:339-45.
33. Ge HY, Wang Y, Danneskiold-Samsøe B, et al.: The predetermined sites of examination for tender points in fibromyalgia syndrome are frequently associated with myofascial trigger points. J Pain. 2010;11:644-651. This article shows that most of the TePs sites in FMS are TrPs. It underlines the role of TrPs as peripheral generators of fibromyalgia pain and suggests that their inactivation may be an important option for the treatment of FMS.
34. Staud R, Nagel S, Robinson ME, Price DD: Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. Pain 2009;145:96-104. This article emphasizes the important role of peripheral impulse input in maintaining central sensitization in FMS by showing a reduction of local and distant hyperalgesia upon anesthetic injection of the trapezius tender point.
35. Affaitati G, Costantini R, Fabrizio A, et al.: Effects of treatment of peripheral pain generators in fibromyalgia patients. Eur J Pain 2011; 15:61-9. This article provides clear evidence of the effects of local treatment of TrPs (not coinciding with the sites of TePs) on pain symptoms of fibromyalgia using a standardized experimental approach.
36. Castro-Sánchez AM, Matarán-Peñarrocha GA, Granero-Molina J, et al. Benefits of massage-myofascial release therapy on pain, anxiety, quality of sleep, depression, and quality of life in patients with fibromyalgia. Evid Based Complement Alternat Med. 2011;2011:561-73.
37. Staud R. Is it all central sensitization? Role of peripheral tissue nociception in chronic musculoskeletal pain. Curr Rheumatol Rep. 2010;12:448-54.